SCHEMBL23391720

SCHEMBL23391720

CC(C)(C)[Si](OCCCc1ccc2c(c1)[nH]c1ccncc12)(c1ccccc1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 4/20 0.41
▸ KIF11 P52732 2/20 0.40
▸ MAPT P10636 4/20 0.36
▸ HTR6 P50406 2/20 0.34
▸ ROCK2 O75116 2/20 0.34
▸ CHEK1 O14757 1/20 0.34
▸ PARP1 P09874 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ GABRP O00591 1/20 0.33
▸ GABRD O14764 1/20 0.33
▸ IKBKB O14920 1/20 0.33
▸ AURKA O14965 1/20 0.33
▸ CHUK O15111 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ PIM1 P11309 1/20 0.33
▸ TOP1 P11387 1/20 0.33
▸ GABRA1 P14867 1/20 0.33
▸ IDO1 P14902 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ GABRB1 P18505 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30888260 0.84 KIF11 (0.44) ACHEKIF11MAPTHTR6ROCK2
SCHEMBL23391717 0.76 HDAC3 (0.33) ACHEROCK2KDM4EALDH1A1HPGD
SCHEMBL30544629 0.73 NR1H2 (0.37) GABRG2GABRB3GABRA5
SCHEMBL14053477 0.72 KIF11 (0.54) ACHEKIF11MAPTHTR6PARP1
SCHEMBL3684392 0.70 PPARG (0.38) ALDH1A1IDO1MAOBSMN1; SMN2
SCHEMBL6487611 0.70 CALM1 (0.41) ACHEKDM4EALDH1A1
SCHEMBL14053792 0.70 KIF11 (0.56) ACHEKIF11MAPTHTR6PARP1
SCHEMBL20652671 0.69 ACHE (0.51) ACHEKIF11MAPTROCK2CHEK1
SCHEMBL9343520 0.69 HRH3 (0.38) IDO1
SCHEMBL14053621 0.69 KIF11 (0.49) ACHEKIF11MAPTHTR6PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12622901-B2 Compounds for tau protein degradation DANA-FARBER CANCER INSTITUTE, INC. (US) 2026-05-12 — — US disclosed
US-20240091213-A1 COMPOUNDS FOR TAU PROTEIN DEGRADATION DANA-FARBER CANCER INSTITUTE, INC. (US) 2024-03-21 — — US disclosed
EP-4310496-A2 COMPOUNDS FOR TAU PROTEIN DEGRADATION Dana-Farber Cancer Institute, Inc. (US) 2024-01-24 — — EP disclosed
US-20210154184-A1 COMPOUNDS FOR TAU PROTEIN DEGRADATION DANA-FARBER CANCER INSTITUTE, INC. (US) 2021-05-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240091213-A1 COMPOUNDS FOR TAU PROTEIN DEGRADATION UBQLN1, UBQLN2, CRBN ACHE 344/4885KIF11 922/4885MAPT 4/4885
US-12622901-B2 Compounds for tau protein degradation MAPT, UBQLN1, PSEN1 ACHE 236/4885KIF11 421/4885MAPT 1/4885
US-20210154184-A1 COMPOUNDS FOR TAU PROTEIN DEGRADATION UBQLN1, UBQLN2, CRBN ACHE 344/4885KIF11 922/4885MAPT 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback